Technologies related to In vivo data available (animal)

Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014/1 | Updated: Feb 14, 2018
Regenerative Therapy for Cartilage Damage
Ref: E-152-2017/0 | Updated: Jan 25, 2018
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016/0 | Updated: Oct 31, 2017
Development of a Transferrable Norwalk Virus Epitope and Detector Monoclonal Antibody
Ref: E-101-2013/0 | Updated: Sep 5, 2017
Whole Animal Feeding Flat (WAFFL): A High-throughput Platform for the Automated Handling of Flies
Ref: E-034-2015/0 | Updated: Nov 7, 2017
Transgenic Mice Expressing CNO-sensitive Gq- or Gs-coupled Designer Receptors Selectively in Pancreatic Beta Cells
Ref: E-197-2016/0 | Updated: Apr 17, 2017
A New Class of Stable Heptamethine Cyanine Fluorophores and Biomedical Applications Thereof
Ref: E-271-2014/0 | Updated: Nov 22, 2017
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011/0 | Updated: Jan 26, 2017
Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
Ref: E-195-2014/0 | Updated: Dec 1, 2016
Methods of Making and Using Dopamine D3 Receptor Selective Antagonists/Partial Agonists
Ref: E-053-2016/0 | Updated: Mar 8, 2017
Use of Roseomonas Species to Treat Eczematous (Atopic Dermatitis) Skin Disease
Ref: E-099-2016/0 | Updated: Oct 27, 2016
Conserved Element Vaccines for HIV
Ref: E-087-2015/0 | Updated: Aug 8, 2016
Improved Fixative for Paraffin-Embedded Tissue Samples
Ref: E-139-2015/0 | Updated: Jul 7, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
Ref: E-208-2015/0 | Updated: Jan 4, 2016
Assays for Measuring and Quantifying DNA Damage from Ionizing Radiation, Chemotherapeutic Agents, and Environmental Agents
Ref: E-276-2014/0 | Updated: Dec 1, 2015
Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
Ref: E-292-2015/0 | Updated: May 24, 2016
Optimized Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia
Ref: E-039-2015/0 | Updated: Apr 26, 2017
Detection and Discrimination of Classical and Atypical L-Type BSE Strains by RT-QuIC
Ref: E-048-2015/0 | Updated: Sep 23, 2015
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
mNFHcre Transgenic Mice
Ref: E-293-2009/0 | Updated: Aug 10, 2015
Novel Treatment for Anemia and Polycythemia: AVPR1B Molecules Modulating Erythropoiesis
Ref: E-619-2013/0 | Updated: Aug 6, 2015
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015/0 | Updated: Nov 1, 2017
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015/0 | Updated: Nov 1, 2017
WNT1-Induced Secreted Protein-1 Knockout Mouse Model
Ref: E-234-2015/0 | Updated: Aug 6, 2015
Magnetic Resonance Magnification Imaging
Ref: E-252-2014/0 | Updated: Jan 12, 2017
Bispecific Chimeric Antigen Receptors to CD22 and CD19 for Treating Hematological Cancers
Ref: E-106-2015/0 | Updated: Feb 9, 2017
Method of Treating Fumarate Hydratase-deficient Kidney Cancer
Ref: E-104-2014/0 | Updated: Sep 10, 2015
Boron Amino Acid Mimetics for PET Imaging of Cancer
Ref: E-135-2015/0 | Updated: Jun 29, 2015
A Novel Therapeutic Vector for Hemoglobin Disorders
Ref: E-165-2014/0 | Updated: Sep 21, 2015
Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
Ref: E-030-2013/0 | Updated: Sep 5, 2017
Novel Immunotherapy for Cancer Treatment: Chimeric Antigen Receptors Targeting CD70 Antigen
Ref: E-021-2015/0 | Updated: Oct 13, 2015
Live Attenuated Japanese Encephalitis Virus Vaccine
Ref: E-231-2014/0 | Updated: Jul 1, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
89Zr-Oxine Complex for In Vivo PET Imaging of Labelled Cells and Associated Methods
Ref: E-080-2014/0 | Updated: Dec 2, 2015
LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
Ref: E-070-2014/0 | Updated: Mar 22, 2016
Aza-Englerin Analogues - Novel Natural Product-Based Nitrogen-Containing Anti-Cancer Agents
Ref: E-090-2014/0 | Updated: Jan 13, 2015
Polyketal Nanoparticle Delivery of CpG Oligodeoxynucleotide for Treatment of Lung Cancer
Ref: E-159-2014/0 | Updated: Jan 13, 2015
Octopod (8-pointed star-shape) Iron Oxide Nanoparticles Enhance MRI T2 Contrast
Ref: E-314-2013/0 | Updated: Sep 17, 2015
T-cell Chimeric Receptors of TSLPR for Diagnosis and Immunotherapy of Cancer
Ref: E-008-2014/0 | Updated: Nov 20, 2014
High-Titer, Fast-Growth Chimeric Dengue/West Nile Viruses for Vaccine and Diagnostics Development
Ref: E-168-2014/0 | Updated: Nov 14, 2014
Chemotherapeutic Anti-cancer Agents
Ref: E-027-2014/0 | Updated: Oct 27, 2014
The Use of Chimeric Antigen Receptor to Control HIV Infection
Ref: E-212-2014/0 | Updated: Sep 9, 2015
A Current Amplifier for Local Coil Pre-amplification of NMR/MRI Signals
Ref: E-122-2014/0 | Updated: Sep 9, 2015
A Novel Demodulation System in X-ray Imaging
Ref: E-113-2013/0 | Updated: Sep 9, 2015
A Novel X-ray Grating to Enhance Phase Contrast Imaging
Ref: E-114-2013/0 | Updated: Sep 9, 2015
Inhibition of HIV Infection through Chemoprophylaxis Using Emtricitabine and Tenofovir
Ref: E-195-2013/0 | Updated: Sep 25, 2014
A Rabbit Anti-pT1989 ATR Monoclonal Antibody for Use in Immunoassays
Ref: E-001-2014/0 | Updated: Nov 20, 2017
Novel Epstein-Barr Virus Vaccines
Ref: E-531-2013/0 | Updated: Dec 17, 2015
AAV-Vectors for Treatment of Glycogen Storage Disorders
Ref: E-552-2013/0 | Updated: Aug 6, 2014
Cancer Immunotherapy Using Virus-like Particle Containing Alphavirus Replicons Coding for Therapeutic Proteins
Ref: E-050-2014/0 | Updated: Jun 27, 2016
Implantable Medical Devices with Electric Current Retrieval Assist
Ref: E-088-2014/0 | Updated: Aug 6, 2014
Small Molecule Imaging of Fungi by Positron Emission Tomography Scanning
Ref: E-449-2013/0 | Updated: Feb 13, 2017
Multifunctional RNA Nanoparticles as Therapeutic Agents
Ref: E-765-2013/0 | Updated: Nov 14, 2016
Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
Ref: E-275-2013/0 | Updated: Nov 30, 2016
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013/0 | Updated: Jun 2, 2014
RNA Splicing Inhibitors to Treat Cancers
Ref: E-065-2014/0 | Updated: Jun 9, 2014
Improved Acoustic Plethysmograph System for Noninvasive Measurement of Pulmonary Function
Ref: E-290-2013/0 | Updated: Jun 9, 2014
Multi-specific Chimeric Antigen Receptors Against HIV
Ref: E-170-2013/0 | Updated: Oct 23, 2017
Treating or Inhibiting JC Polyomavirus Infection and JC Polyomavirus-Associated Progressive Multifocal Leukoencephalopathy
Ref: E-549-2013/0 | Updated: Apr 15, 2014
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013/0 | Updated: Apr 14, 2014
SCGB3A2 for Treatment of Cancer
Ref: E-286-2006/3 | Updated: Apr 15, 2014
Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
Ref: E-751-2013/0 | Updated: Nov 18, 2015
Dengue Vaccines: Tools for Redirecting the Immune Response for Safe, Efficacious Dengue Vaccination
Ref: E-289-2013/0 | Updated: Mar 18, 2014
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013/0 | Updated: Mar 18, 2014
Computer Controlled Aerosol Generator with Multi-Walled Carbon Nanotube Inhalation Testing Capabilities
Ref: E-156-2013/0 | Updated: Mar 17, 2014
Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
Ref: E-470-2013/0 | Updated: May 24, 2016
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012/0 | Updated: Apr 15, 2014
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013/0 | Updated: Feb 19, 2014
CD40 Ligand: Adjuvant for Enhanced Immune Response to Respiratory Syncytial Virus
Ref: E-233-2013/0 | Updated: Feb 6, 2014
Multivalent Immunogenic Peptides (Vaccines) for the Treatment of Prostate and Breast Cancer
Ref: E-047-2014/0 | Updated: Oct 23, 2017
Novel Immunocytokine for the Treatment of Cancer
Ref: E-118-2013/0 | Updated: Jan 31, 2014
Stable, Early-stage Biomarker for Diagnosis of Bacillus anthracis Infection and Anthrax Vaccine Development
Ref: E-474-2013/0 | Updated: Mar 3, 2017
Recombinant Nucleic-Acid Based Flavivirus Nucleic Acids for Development of Vaccines and/or Sero-diagnostics
Ref: E-341-2013/0 | Updated: Jan 28, 2014
Virus Replicon Particles as Rift Valley Fever Vaccines
Ref: E-272-2013/0 | Updated: Aug 8, 2016
Select M. tuberculosis Peptides as Mucosal Vaccines Against Pulmonary Tuberculosis
Ref: E-192-2013/0 | Updated: Jan 27, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013/0 | Updated: Mar 3, 2017
Multi-Antigenic Peptide(s) Vaccine and Immunogen for Conferring Streptococcus pneumoniae Immunity
Ref: E-248-2013/1 | Updated: Jan 27, 2014
Sensitive Method for Detection and Quantification of Anthrax, Bordetella pertussis, Clostridium difficile, Clostridium botulinum and Other Pathogen-Derived Toxins in Human and Animal Plasma
Ref: E-167-2013/0 | Updated: Mar 3, 2017
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013/0 | Updated: Jan 16, 2014
Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
Ref: E-081-2013/0 | Updated: Feb 11, 2016
Improved Therapeutic Immunotoxins
Ref: E-771-2013/0 | Updated: Sep 6, 2017
Bispecific Antibodies to Target Latent HIV-1 Infection
Ref: E-071-2012/0 | Updated: Jan 6, 2014
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013/0 | Updated: Feb 13, 2014
Novel Rift Valley Fever Virus Vaccines
Ref: E-254-2013/2 | Updated: Dec 23, 2013
Chimeric Antigen Receptors to ALK for Treating Neuroblastoma and Other Solid Tumors
Ref: E-007-2014/0 | Updated: Jan 18, 2018
Her2 Monoclonal Antibodies, Antibody Drug Conjugates, and Site Specific Antibody Conjugate Methods
Ref: E-351-2013/0 | Updated: Nov 28, 2017
Intravenous Water Soluble Formulation of MJC13 – A Novel Lead Compound for the Treatment of Castrate-resistant Prostate Cancer
Ref: E-065-2013/0 | Updated: Dec 19, 2013
Methods of Modulating Chemotherapeutic Cytotoxicity
Ref: E-296-2011/0 | Updated: Sep 21, 2015
Use of Antisense Oligodeoxynucleotides for Inhibiting JC Virus
Ref: E-547-2013/0 | Updated: Feb 11, 2016
Mouse Model for Methylmalonic Acidemia, an Inherited Metabolic Disorder
Ref: E-285-2011/1 | Updated: Dec 3, 2013
Reporter Plasmid to Identify Cancer Stem Cells
Ref: E-141-2011/0 | Updated: Dec 1, 2015
AAV-Aquaporin-1 Gene Therapy for Sjogren's Syndrome
Ref: E-139-2011/1 | Updated: Dec 14, 2016
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013/0 | Updated: Apr 11, 2014
Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery
Ref: E-482-2013/0 | Updated: Aug 16, 2017
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012/0 | Updated: Aug 11, 2015
Antagonists of Hyaluronan Signaling for Treatment of Airway Diseases
Ref: E-080-2012/0 | Updated: Oct 3, 2017
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011/0 | Updated: Jun 18, 2014
Vaccine to Prevent BK Polyomavirus-associated Kidney and Bladder Infections in Organ Transplant Recipients
Ref: E-168-2011/0 | Updated: Nov 17, 2017
15kD Granulysin for Monocyte Differentiation: A New Immunotherapeutic for Both in vivo and ex vivo Applications
Ref: E-158-2009/0 | Updated: Oct 23, 2017


Subscribe to Technologies related to In vivo data available (animal)